ZNF423 and precursor B-cell acute lymphoblastic leukemia: Thus, several lines of experimental evidence suggest that ZFP423 and ZFP521 may cooperate with oncogenic lesions and contribute to B-ALL development, presumably through the inhibition of EBF1 and the consequent disruption of the functional network that governs normal B-cell differentiation.